Skip to content
Open access

Cumulative incidence and risk factors of dementia in Parkinson's disease and parkinsonism: a population-based study

Aug 2026 · Brain Communications · Vol 8 · 0 citations · 95 references
Medicine

TL;DR

Findings were largely confirmed in the Parkinson’s disease/Parkinson’s disease with dementia group, in which 77 (13.5%) developed mild cognitive impairment and 249 (43.5%) developed dementia, supporting a potential involvement of non-dopaminergic and central autonomic pathways in cognitive decline.

Abstract

Abstract Cognitive impairment is among the most common non-motor symptoms in parkinsonism and Parkinson’s disease, ranging from subjective complaints to dementia. Although several predictive factors have been described, their prognostic relevance remains uncertain. This study aimed to examine the predictive association between clinical features and the risk of dementia and determine the incidence of dementia in a population-based cohort of incident Parkinsonism cases. Patients with parkinsonism onset between 1991 and 2020 were identified using the Rochester Epidemiology Project records-linkage system. Subjects with cognitive impairment preceding motor symptoms onset or concomitant Alzheimer’s disease were excluded. Diagnoses of dementia and mild cognitive impairment were established using neuropsychological testing or brief cognitive screening. Development of dementia was assessed using a Cox proportional hazards regression model. Associations between dementia and each risk factor were individually estimated in adjusted Cox models. All risk factors were also included in a least absolute shrinkage and selection operator penalized multivariable Cox model. A total of 1104 patients were included: 153 (13.9%) developed mild cognitive impairment, and 543 (49.2%) developed dementia during follow-up. The cumulative incidence of dementia was 30.3% at 5 years, 48.6% at 10 years, 61.4% at 15 years and 69.3% at 20 years, indicating that a considerable portion of patients remained free of dementia after a prolonged follow-up. The majority of patients with dementia were males (61.5%), and older age at disease onset was associated with risk of dementia (hazard ratio [HR] = 1.32, P < 0.001 per 5-year increment). In the penalized model, dementia risk was significantly higher among individuals presenting with impaired postural reflexes (HR = 1.26, P = 0.014), consistent with a poorer prognosis in akinetic-rigid-predominant parkinsonism. Eye movement abnormalities, including reduced ocular range of motion (HR = 1.86, P < 0.001) and smooth pursuit alterations (HR = 1.34, P = 0.024), were also associated with dementia. Non-motor symptoms, including rapid eye movement sleep behaviour disorder (HR = 1.51, P < 0.001), orthostatic hypotension (HR = 1.30, P = 0.009) and constipation (HR = 1.24, P = 0.022), were linked to dementia risk, supporting a potential involvement of non-dopaminergic and central autonomic pathways in cognitive decline. These findings were largely confirmed in the Parkinson’s disease/Parkinson’s disease with dementia group, in which 77 (13.5%) developed mild cognitive impairment and 249 (43.5%) developed dementia. Among these patients, smooth pursuit alterations, reduced ocular range of motion, orthostatic hypotension and constipation were associated with dementia.

Read PDF

Similar papers

Review Open access Sep 2026

Neuropsychiatric symptoms as predictors of progression to Alzheimer's disease in mild cognitive impairment: A comparative meta-analysis of apathy, depression, and anxiety.

Apathy is a robust and consistent behavioral predictor of progression from MCI to clinical AD dementia, and domain-specific neuropsychiatric assessment may improve future risk stratification.

Yu-Ying Sun, Yu Cao, Jin-Ye Ma et al. · 1 citation
Open access Jul 2026

Severity and progression of visual impairment and risk of dementia

Visual impairment is associated with dementia risk, but the role of severity and longitudinal change remains unclear. We examined whether visual impairment severity and its progression were associated with incident dementia.

A. Lee, O. Leung, Zhao-Hua Huo et al. · 0 citations
Open access Sep 2026

Sex- and age-specific associations between modifiable risk factors and incident Alzheimer’s disease dementia: a nationwide cohort study in Korea

The associations between modifiable risk factors and incident Alzheimer's disease dementia exhibited distinct sex- and age-specific patterns, highlighting the importance of tailored dementia prevention strategies that account for differences in demographic characteristics and risk factor profiles.

H. Kim, M. Oh · 0 citations
Open access Sep 2026

Population-based cohort study of modifiable risk factors for dementia and Alzheimer disease mortality in Spain

Late-life depressive symptoms emerged as the most prominent modifiable correlate of dementia- and AD-coded mortality, supporting improved recognition and management of depressive symptoms in older adults.

J. Benito-León, J. I. Serrano, M. D. del Castillo et al. · 1 citation
Review Open access Aug 2026

Prevalence, predictors, and emerging biomarkers for cognitive impairment and neuropsychiatric manifestations in Parkinson's disease in Africa: A systematic review

Background Cognitive impairment and neuropsychiatric manifestations are common disabling non-motor symptoms that can negatively impact quality of life in Parkinson's disease. This review aimed to critically appraise and synthesize evidence on the prevalence, predictors, and emerging biomarkers of cognitive impairment a...

M. Njohjam, F. Niakam, M. Ngoule · 0 citations
Open access Oct 2026

Predictors of Seizure Occurrence After Mild Cognitive Impairment and Alzheimer's Disease in Older Adults in the Veterans Affairs Healthcare System: A Retrospective Cohort Study.

INTRODUCTION This was a retrospective epidemiological study to identify the predictors of incidence seizures among older adults with all-cause mild cognitive impairment (MCI) and Alzheimer's disease (AD) receiving care in the Veterans Affairs Healthcare System (VAHS). METHODS Veterans aged ≥ 50 years with MCI or AD w...

Myriam Abdennadher, Ying Wang, J. Reisman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.